FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/08/2024
Voltar para busca
Dado oficial do USPTO
PHINDER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
11/08/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 44
Data de depósito
11/04/2022
Data de registro
12/03/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/03/2024
Última transação
12/03/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
24
Localização do titular
SG
Examinador
HARMON, RAYMOND E
Unidade examinadora
L30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
MIRXES PTE. LTD.
Representantes
Joseph G. Chu JCIP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic preparations for medical and veterinary use or purposes; reactants for medical and veterinary diagnosisreagents for medical use; diagnostic preparations for medical use for sale in kit form; diagnostic products for medical purposesmedical diagnostic reagents; indicators for medical diagnosismedical diagnostic reagents; veterinary diagnostic reagents; reagents in kit form for conducting Real Time Polymerase Chain Reaction assays (RT-PCR) for medical or veterinary purposes; reagents for medical or veterinary purposes; reagents for use in diagnostic tests for medical or veterinary purposes; medical diagnostic reagents for testing of body fluids; stem cells for medical and veterinary purposes; substances for use in genetic probe assay kits for medical usereagents for use in medical testing; preparations for medical diagnostic use; biochemical diagnostic preparations for medical diagnostic use; products for medical diagnosismedical diagnostic reagents; diagnostic agents for pharmaceutical use; test reagents for medical diagnosis; diagnostic biomarker reagents for medical purposes; chemical preparations for diagnostic purposes; chemical preparations for use in RNA and DNA analysisreagents for use in medical testing; chemical products for medical analysisreagents for use in medical testing; preparations for detecting genetic predispositions for medical purposes; reagents for medical analytical purposes; synthetic deoxyribonucleic acid and synthetic ribonucleic acid for medical use; nucleic acid amplification reagents for medical use
Classe 10
Medical diagnostic apparatusmedical diagnostic apparatus for detecting pulmonary hypertension; medical diagnostic instrumentsmedical diagnostic apparatus for detecting pulmonary hypertension; biomedical testing apparatusapparatus for DNA and RNA testing for medical purposes; tools for medical diagnosticsapparatus for DNA and RNA testing for medical purposes; medical instruments for infectious disease testing; testing apparatus for sale in kit form for medical diagnostic purposesapparatus for DNA and RNA testing for medical purposes; medical diagnostic testing apparatusapparatus for DNA and RNA testing for medical purposes; in-vitro diagnostic testing apparatus for medical useapparatus for DNA and RNA testing for medical purposes; diagnostic testing apparatus for use in molecular diagnostic procedures for medical purposesapparatus for DNA and RNA testing for medical purposes; apparatus for blood tests for medical use
Classe 44
Medical diagnostic servicesmedical diagnostic testingmonitoring and reporting services; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for the diagnosis of cancer; genetic testing for medical purposesRNA and DNA analysis for pulmonary hypertension diagnosis and prognosis; performing diagnosis of diseases; medical analysis services for the diagnosis of conditions of the human body; medical laboratory services related to the treatment of patientsmedical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis for the diagnosis and treatment of persons; health assessment services by means of conducting health risk assessment surveys; health-care services; genetic testing for medical purposes; genetic testingRNA and DNA screening for medical purposes; medical analysis services for the diagnosis of pulmonary hypertension; medical screening; medical screeninghealth screening
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/07/2024
FIMP
FINAL DISPOSITION PROCESSED
18/07/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/06/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2024
GPNX
NOTIFICATION PROCESSED BY IB
26/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/12/2023
PUBO
PUBLISHED FOR OPPOSITION
26/12/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/12/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/12/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/12/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/11/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
22/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/09/2023
RFNT
REFUSAL PROCESSED BY IB
19/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/03/2023
RFRR
REFUSAL PROCESSED BY MPU
30/03/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/02/2023
CNRT
NON-FINAL ACTION WRITTEN
07/02/2023
DOCK
ASSIGNED TO EXAMINER
27/01/2023
MAFR
APPLICATION FILING RECEIPT MAILED
21/06/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/06/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/06/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PHINDER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.